Publication Name	World Journal of Transplantation
Manuscript ID	28883
Country	United States

Received	2016-07-19 18:16
Peer-Review Started	2016-07-21 14:33
To Make the First Decision	2016-09-05 09:13
Return for Revision	2016-09-05 17:18
Revised	2016-09-28 20:16
Second Decision	2016-10-10 09:36
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-10-24 14:46
Articles in Press	2016-10-24 14:46
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-12-05 14:33
Publish the Manuscript Online	2016-12-14 14:32

ISSN	2220-3230 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Minireviews
Article Title	Overview of the progress on haploidentical hematopoietic transplantation
Manuscript Source	Invited Manuscript
All Author List	Nosha Farhadfar and William J Hogan
Funding Agency and Grant Number
Corresponding Author	William J Hogan, MBBCh, MRCPI, Division of Hematology, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States. hogan.william@mayo.edu
Key Words	Haploidentical donor; Hematopoietic stem cell transplantation; Hematological malignancies; Transplant related mortality
Core Tip	Over the past decade, haploidentical donors have emerged as a viable alternate graft source for patients without a HLA-matched donor. Several strategies including graft manipulation, conditioning regimen optimization and better graft-versus-host disease control have significantly improved the outcomes of haploidentical hematopoietic stem cell transplant (HSCT). Here, we summarize some of the recent advances in the field of haploidentical HSCT in adults.
Publish Date	2016-12-14 14:32
Citation	Farhadfar N, Hogan WJ. Overview of the progress on haploidentical hematopoietic transplantation. WoWorld J Transplant 2016; 6(4): 665-674
URL	http://www.wjgnet.com/2220-3230/full/v6/i4/665.htm
DOI	http://dx.doi.org/10.5500/wjt.v6.i4.665

Full Article (PDF)	WJT-6-665.pdf
Full Article (Word)	WJT-6-665.doc
Manuscript File	28883-Review.docx
Answering Reviewers	28883-Answering reviewers.pdf
Audio Core Tip	28883-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	28883-Conflict-of-interest statement.pdf
Copyright License Agreement	28883-Copyright assignment.pdf
Peer-review Report	28883-Peer-review(s).pdf
Scientific Misconduct Check	28883-Scientific misconduct check.pdf
Scientific Editor Work List	28883-Scientific editor work list.pdf